Christos Kyriakopoulos, MD, MSCI

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    BMS
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    ESSA Pharma
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Gilead Sciences
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Madison Vaccines, Inc
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck KGaA
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Merck
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pionyr Immunotherapeutics
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sanofi-Aventis
    Topic:
    Research support to institution
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Advisory board
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    05/07/2024

Pages

Return to Best of ASCO 2024, Milwaukee